LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-b]indole-ketones and analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Pyrrolo[2,3-b]pyridin-4-yl-amines and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-c]pyridine derivatives and processes for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-C]pyridines and their use as anti-hypertensive agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-D]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-D]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine cytokine inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine cytokine inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[2,3-d]pyrimidine derivatives substituted with a...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Pyrrolo[2,3-d]pyrimidine derivatives, process for producing the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Pyrrolo[2,3-d]pyrimidine nucleosides as antiviral agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Pyrrolo[2,3-d]Pyrimidines as Protein Tyrosine Kinase Inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[3,2-c]pyridine derivatives and processes for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Pyrrolo[3,2-D] pyrimidines that are selective antagonists of...